Centric Health Corp. (TSE:CRX – Free Report) – Research analysts at Desjardins decreased their FY2024 earnings per share estimates for Centric Health in a note issued to investors on Sunday, November 10th. Desjardins analyst G. Ho now expects that the company will earn ($0.03) per share for the year, down from their previous estimate of ($0.02).
Several other analysts have also recently commented on CRX. Stifel Canada cut shares of Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th. Ventum Cap Mkts upgraded Centric Health to a “strong-buy” rating in a report on Thursday, August 8th.
Centric Health Stock Performance
Recommended Stories
- Five stocks we like better than Centric Health
- Using the MarketBeat Stock Split Calculator
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- The Role Economic Reports Play in a Successful Investment Strategy
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
